Industry may be its own obstacle to success in achieving the desired high-performance state.
Michael Brueckner
Advertisement
Articles by Michael Brueckner
Advertisement
Latest Updated Articles
Biopharmaceutical High PerformancePublished: August 1st 2011 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
5
